Omega-3 Supplements to Reduce Antisocial Behaviour in Young Offenders
NCT03627312 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 181
Last updated 2018-08-13
Summary
The study aims to examine the effects of providing omega-3 supplements on young offenders' antisocial behaviour. Participants will be randomized into three groups: (1) Omega-3, (2) Placebo and (3) Treatment as Usual. Self report and correctional officer ratings of behaviour will be assessed at 0 months (baseline), 3 months (end of supplementation), 6 months and 12 months. The investigators hypothesize that omega-3 supplementation will reduce antisocial behaviour among the young offenders.
Conditions
- Antisocial Behavior
Interventions
- COMBINATION_PRODUCT
-
Omega-3
1g of omega-3 supplement to be taken per day for a duration of 3 months in the form of a fruit juice drink
- COMBINATION_PRODUCT
-
Placebo
Fruit juice drink only
- OTHER
-
Treatment as Usual
Young Offenders Intervention Programme
Sponsors & Collaborators
- collaborator OTHER
-
Singapore Prison Service
lead OTHER_GOV
Principal Investigators
-
Adrian Raine · University of Pennsylvania
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Max Age
- 21 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-03-01
- Primary Completion
- 2013-07-31
- Completion
- 2013-07-31
More Related Trials
-
The Impact of Supplementation With Multi-vitamins/Minerals, With and Without Fatty Acids, on Impulsivity and Aggression
NCT01558193 ·Status: COMPLETED ·Phase: NA
-
Investigation of Psychophysiological Response to Aversive Stimuli Over Time With Omega-3
NCT03749824 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids for Autism Treatment
NCT00786799 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Omega-3 Supplements on Stress, Anxiety, Depression, Memory and Sleep Quality Among Saudis
NCT07157241 ·Status: COMPLETED ·Phase: NA
-
Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention
NCT00519779 ·Status: COMPLETED ·Phase: PHASE2
-
The Combination Effect of Citicoline and Omega-3
NCT03444662 ·Status: COMPLETED ·Phase: NA
-
Omega-3, Inflammation in ADHD With AI
NCT07348562 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Evaluate the Efficacy and the Tolerance of an Omega 3 Fatty Acids Supplementation in ADHD Children
NCT00770627 ·Status: UNKNOWN ·Phase: PHASE4
-
Omega-3 and Therapy Study for Depression
NCT01341925 ·Status: COMPLETED ·Phase: PHASE1
-
Open Label of Clinical Trial of Sulforaphane in Children With Autism
NCT02654743 ·Status: COMPLETED ·Phase: PHASE3
-
Intervention With Omega-3 in Children With Attention Deficit Hyperactivity Disorder(ADHD)
NCT02986672 ·Status: COMPLETED ·Phase: NA
-
Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders
NCT00467818 ·Status: COMPLETED ·Phase: NA
-
Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms
NCT06698588 ·Status: RECRUITING ·Phase: NA
-
Dietary Counselling Plus Omega-3 Supplementation in the Treatment of Generalized Anxiety Disorder
NCT05573672 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Omega-3 Fatty Acids on Kynurenine Metabolism and Mood
NCT05520437 ·Status: UNKNOWN ·Phase: NA
-
Omega-3 Fatty Acids in Autism Spectrum Disorders
NCT01695200 ·Status: COMPLETED ·Phase: PHASE4
-
NAPLS Omega-3 Fatty Acid Versus Placebo Study
NCT01429454 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing Aggression Among People With an Intellectual Disability
NCT03212092 ·Status: COMPLETED ·Phase: NA
-
Effect of Omega-3 Fatty Acid on Neurobehavioral Status of Children With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo Controlled Trial
NCT06125782 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of 8-Week Dietary DHA Supplementation on Cerebral Blood Flow and Metabolic Function
NCT00662142 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Omega-3 Polyunsaturated Fatty Acids in the Treatment and Prevention of Relapse of Bipolar Disorder
NCT01371383 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD
NCT01778647 ·Status: TERMINATED ·Phase: PHASE4
-
The Correlation Between Blood omega3 and ADHD
NCT02391428 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Study of Omega-3 Fatty Acids Regarding Ergogenic, Anti-inflammatory and Obesity Inhibitory Effects in 8 Year Old Children
NCT01323283 ·Status: COMPLETED ·Phase: NA
-
Effect of Omega-3 Supplementation During Pregnancy on Regulation of Stress
NCT01158976 ·Status: COMPLETED ·Phase: NA